vs
Side-by-side financial comparison of Citi Trends Inc (CTRN) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($250.2M vs $197.1M, roughly 1.3× Citi Trends Inc). USANA HEALTH SCIENCES INC runs the higher net margin — 3.0% vs -3.5%, a 6.5% gap on every dollar of revenue. On growth, Citi Trends Inc posted the faster year-over-year revenue change (10.1% vs -3.0%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (11.8% CAGR vs -4.3%).
Citi Trends, Inc. is an American retail clothing chain selling discounted products targeted primarily at African-American customers.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
CTRN vs USNA — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $197.1M | $250.2M |
| Net Profit | $-6.9M | $7.5M |
| Gross Margin | — | 76.2% |
| Operating Margin | -3.7% | 5.5% |
| Net Margin | -3.5% | 3.0% |
| Revenue YoY | 10.1% | -3.0% |
| Net Profit YoY | 3.6% | -20.0% |
| EPS (diluted) | $-0.86 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $250.2M | ||
| Q4 25 | $197.1M | $226.2M | ||
| Q3 25 | $190.8M | $213.7M | ||
| Q2 25 | $201.7M | $235.8M | ||
| Q1 25 | $211.2M | $249.5M | ||
| Q4 24 | $179.1M | $213.6M | ||
| Q3 24 | $176.6M | $200.2M | ||
| Q2 24 | $186.3M | — |
| Q1 26 | — | $7.5M | ||
| Q4 25 | $-6.9M | $180.0K | ||
| Q3 25 | $3.8M | $-6.5M | ||
| Q2 25 | $871.0K | $9.7M | ||
| Q1 25 | $-14.2M | $9.4M | ||
| Q4 24 | $-7.2M | $4.5M | ||
| Q3 24 | $-18.4M | $10.6M | ||
| Q2 24 | $-3.4M | — |
| Q1 26 | — | 76.2% | ||
| Q4 25 | — | 78.2% | ||
| Q3 25 | — | 77.2% | ||
| Q2 25 | — | 78.7% | ||
| Q1 25 | — | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.4% | ||
| Q2 24 | — | — |
| Q1 26 | — | 5.5% | ||
| Q4 25 | -3.7% | 1.7% | ||
| Q3 25 | 1.8% | 0.6% | ||
| Q2 25 | 0.2% | 7.1% | ||
| Q1 25 | 0.6% | 6.3% | ||
| Q4 24 | -4.9% | 3.8% | ||
| Q3 24 | -14.1% | 7.8% | ||
| Q2 24 | -3.7% | — |
| Q1 26 | — | 3.0% | ||
| Q4 25 | -3.5% | 0.1% | ||
| Q3 25 | 2.0% | -3.1% | ||
| Q2 25 | 0.4% | 4.1% | ||
| Q1 25 | -6.7% | 3.8% | ||
| Q4 24 | -4.0% | 2.1% | ||
| Q3 24 | -10.4% | 5.3% | ||
| Q2 24 | -1.8% | — |
| Q1 26 | — | $0.41 | ||
| Q4 25 | $-0.86 | $-0.10 | ||
| Q3 25 | $0.46 | $-0.36 | ||
| Q2 25 | $0.11 | $0.52 | ||
| Q1 25 | $-1.70 | $0.49 | ||
| Q4 24 | $-0.86 | $0.23 | ||
| Q3 24 | $-2.21 | $0.56 | ||
| Q2 24 | $-0.42 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $162.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $107.8M | — |
| Total Assets | $464.3M | $739.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $162.8M | ||
| Q4 25 | — | $158.4M | ||
| Q3 25 | — | $145.3M | ||
| Q2 25 | — | $151.3M | ||
| Q1 25 | — | $179.6M | ||
| Q4 24 | — | $181.8M | ||
| Q3 24 | — | $364.9M | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $107.8M | — | ||
| Q3 25 | $113.2M | $528.1M | ||
| Q2 25 | $108.6M | $531.1M | ||
| Q1 25 | $113.2M | $529.8M | ||
| Q4 24 | $130.3M | $532.1M | ||
| Q3 24 | $136.6M | $533.1M | ||
| Q2 24 | $154.8M | — |
| Q1 26 | — | $739.0M | ||
| Q4 25 | $464.3M | $742.9M | ||
| Q3 25 | $457.4M | $726.6M | ||
| Q2 25 | $437.4M | $734.5M | ||
| Q1 25 | $462.8M | $746.6M | ||
| Q4 24 | $467.1M | $748.2M | ||
| Q3 24 | $506.7M | $671.3M | ||
| Q2 24 | $484.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.6M | — |
| Free Cash FlowOCF − Capex | $767.0K | — |
| FCF MarginFCF / Revenue | 0.4% | — |
| Capex IntensityCapex / Revenue | 4.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $11.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.6M | — | ||
| Q3 25 | $3.9M | $-2.0M | ||
| Q2 25 | $-11.0M | $12.2M | ||
| Q1 25 | $28.5M | $15.5M | ||
| Q4 24 | $-18.4M | $5.8M | ||
| Q3 24 | $5.6M | $29.5M | ||
| Q2 24 | $-19.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | $767.0K | — | ||
| Q3 25 | $-1.7M | $-5.2M | ||
| Q2 25 | $-13.1M | $7.2M | ||
| Q1 25 | $26.0M | $12.7M | ||
| Q4 24 | $-20.4M | $4.0M | ||
| Q3 24 | $1.7M | $27.1M | ||
| Q2 24 | $-21.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | — | ||
| Q3 25 | -0.9% | -2.4% | ||
| Q2 25 | -6.5% | 3.0% | ||
| Q1 25 | 12.3% | 5.1% | ||
| Q4 24 | -11.4% | 1.9% | ||
| Q3 24 | 0.9% | 13.6% | ||
| Q2 24 | -11.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.0% | — | ||
| Q3 25 | 2.9% | 1.5% | ||
| Q2 25 | 1.0% | 2.1% | ||
| Q1 25 | 1.2% | 1.1% | ||
| Q4 24 | 1.1% | 0.8% | ||
| Q3 24 | 2.2% | 1.2% | ||
| Q2 24 | 0.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | -12.59× | 1.27× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | — | 2.78× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
